TCWA
WST icon

Ten Capital Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Ten Capital Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25
Closed -$5.88K – 668
2022
Q4 		$5.88K Hold
25
– – ﹤0.01% 368
2022
Q3 		$6K Buy
+25
New +$7.62K ﹤0.01% 391

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ten Capital Wealth Advisors's WST Position: Q1 2023 in Review

Ten Capital Wealth Advisors sold out of West Pharmaceutical (WST) in Q1 2023, closing a stake of 25 shares — an estimated $5.88K sold.

Ten Capital Wealth Advisors first reported a position in WST in Q3 2022 and held it in 2 quarters. The position peaked at $6K in Q3 2022. 696 funds tracked by Wall St. Rank hold WST as of Q1 2023.

  • Ten Capital Wealth Advisors reported no remaining West Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • Ten Capital Wealth Advisors sold 25 West Pharmaceutical shares in Q1 2023, an estimated $5.88K.
  • Ten Capital Wealth Advisors first reported a position in West Pharmaceutical in Q3 2022 and held it in 2 quarters.
  • Ten Capital Wealth Advisors's West Pharmaceutical position peaked at $6K in Q3 2022.
  • 696 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2023.

Based on Ten Capital Wealth Advisors's 13F filing for Q1 2023, filed 4 May 2023.